Clinical Trials on Non-Alcoholic Fatty Pancreas Disease in New Zealand
Total 3228 results
-
Arrowhead PharmaceuticalsCompletedNon-alcoholic SteatohepatitisNew Zealand
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis NASHUnited Kingdom, United States, Australia, New Zealand, Switzerland, Jordan, Georgia, Puerto Rico
-
Enanta Pharmaceuticals, IncICON Clinical Research; Triangle BiostatisticsCompletedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, New Zealand, Canada, France, Puerto Rico
-
Institute of Liver and Biliary Sciences, IndiaWithdrawnNon Alcoholic SteatohepatitisIndia
-
Northwell HealthCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon Alcoholic SteatohepatitisIndia
-
Meridian Bioscience, Inc.CompletedNon-Alcoholic SteatohepatitisUnited States, France, Belgium, United Kingdom
-
GenfitTerminatedNon Alcoholic SteatohepatitisUnited States
-
Weill Medical College of Cornell UniversityRecruitingNon-Alcoholic Fatty Liver DiseaseUnited States
-
Hepanova Inc.UnknownNon-Alcoholic Steatohepatitis (NASH)United States
-
GenMont Biotech IncorporationFu Jen Catholic University HospitalRecruitingNon-Alcoholic Fatty Liver DiseaseTaiwan
-
Columbia UniversityGlaxoSmithKlineCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Institute of Liver and Biliary Sciences, IndiaUnknownNon Alcoholic SteatohepatitisIndia
-
Fu Jen Catholic University HospitalEnrolling by invitationNon-alcoholic Fatty Liver DiseaseTaiwan
-
NeuroBo Pharmaceuticals Inc.RecruitingNON-ALCOHOLIC STEATOHEPATITISUnited States
-
Institute of Liver and Biliary Sciences, IndiaWithdrawnNon Alcoholic SteatohepatitisIndia
-
Immuron Ltd.CompletedNon-alcoholic Steatohepatitis (NASH)United States, Australia, Israel
-
Enanta Pharmaceuticals, IncTerminatedNon-Alcoholic SteatohepatitisUnited States, Canada, Puerto Rico, United Kingdom, Argentina, Germany
-
Mochida Pharmaceutical Company, Ltd.CompletedSteatohepatitisUnited States, Puerto Rico
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon-alcoholic SteatohepatitisIndia
-
Madrigal Pharmaceuticals, Inc.UnknownNon-alcoholic SteatohepatitisUnited States
-
PfizerCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited States
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Belgium, Germany, Taiwan, Austria, United States, Spain, Korea, Republic of, Argentina, Australia, Italy, Japan, Singapore, Netherlands, Slovakia, France, Canada, India
-
Institute of Liver and Biliary Sciences, IndiaUnknownNon-Alcoholic Fatty Liver DiseaseIndia
-
Rockefeller UniversityNational Institutes of Health (NIH); Weill Medical College of Cornell UniversityCompletedObesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
PfizerCompletedNon-Alcoholic Fatty Liver Disease (NAFLD)United States
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Rivus Pharmaceuticals, Inc.RecruitingFatty Liver | Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
PfizerCompletedLiver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
GenfitPremier Research Group plc; NaturalphaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
-
Novo Nordisk A/SActive, not recruitingNon-alcoholic SteatohepatitisSpain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
-
AstraZenecaCompletedNon-cirrhotic Non-alcoholic Steatohepatitis With FibrosisUnited States, Austria, Italy, Thailand, Germany, Korea, Republic of, Japan, Malaysia, New Zealand, Spain, Taiwan, Turkey, Australia, Israel, Argentina, Canada, Greece, South Africa, United Kingdom, France
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisUnited States, France
-
Northwell HealthWithdrawnNon-alcoholic Fatty Liver Disease (NAFLD)United States
-
Mirum Pharmaceuticals, Inc.TerminatedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, Canada, Puerto Rico
-
Novo Nordisk A/SRecruitingNon-alcoholic SteatohepatitisUnited States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more
-
Genentech, Inc.TerminatedNon-alcoholic SteatohepatitisBelgium, United States, Spain, Puerto Rico, France
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Northwell HealthTerminatedNon-Alcoholic Fatty Liver Disease | Probiotics MeSH Descriptor Data 2018 | Interleukin-17 MeSH Descriptor Data 2018United States
-
Institute of Liver and Biliary Sciences, IndiaRecruitingMetabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseIndia
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC)United States, New Zealand
-
Fibronostics USA, IncCompletedNon-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Liver Inflammation | Liver Fibroses | Liver SteatosesUnited States
-
PfizerCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
Institute of Liver and Biliary Sciences, IndiaCompletedLiver CirrhosisIndia
-
Cirius Therapeutics, Inc.Chiltern International Inc.CompletedNon-alcoholic Fatty Liver Disease | NASH - Nonalcoholic Steatohepatitis | Non-alcoholic SteatohepatitisUnited States
-
PfizerCompleted
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico